GLP-1 Brain Fog Is Real. Here Is What Is Actually Causing It.
By Martin Valovsky, Co-founder and Head of Product at Axolt August 2026 | Reading time: about 9 minutes
TL;DR
• A lot of people on Ozempic, Wegovy, Mounjaro or Zepbound report the same thing. Foggy head. Flat energy. Words that will not come.
• It is usually not the drug attacking your brain. Your brain is running short on fuel.
• These medications cut how much you eat, by somewhere between 16 and 40 percent. Less food means fewer vitamins and minerals.
• The nutrients that run low first are the exact ones your brain uses to make energy and neurotransmitters.
• Fast weight loss is also a physical stressor, and the cortisol side of this is still being figured out.
• The fix is not quitting the medication. It is closing the nutritional hole it opens.
The trial everyone expected to win
For a few years the smart money said GLP-1 drugs would turn out to be brain drugs.
The logic was decent. People taking them for diabetes seemed to get dementia less often. Animal studies looked promising. GLP-1 receptors exist in the brain, not just the gut.
So Novo Nordisk ran the biggest test anyone has ever run of a GLP-1 drug in a brain disease. Two trials, EVOKE and EVOKE plus. 3,808 people in the early stages of Alzheimer disease. 40 countries. Two years. The drug tested was oral semaglutide, up to 14 mg a day. Not the injection most people picture.
The result, published in The Lancet in March 2026: it did not work.
Semaglutide did not slow the disease. Biomarkers linked to neuroinflammation and Alzheimer disease did improve, by up to about 10 percent. That was real. It just did not translate into people thinking or functioning any better.
A drug can move a biomarker and still not move a person.
I am not writing this to dunk on a medication. GLP-1 drugs do what they were built to do, and they do it well. I am writing it because the failure tells you something useful about how brains actually work.
You cannot fix a brain by pushing on one lever. It is a system. That is the whole premise behind how we built our formula.
What these drugs actually do to you
GLP-1 medications work in three ways that matter here.
• They make you feel full sooner, so you eat less.
• They slow how fast food leaves your stomach.
• They quiet the part of your brain that nags you about food.
All three are the point. All three are also why the fog shows up.
Someone who used to eat 2,200 calories a day might now eat 1,300. That is not just fewer calories. That is fewer vitamins, fewer minerals, less protein, less of everything that came packaged inside the food.
And because these drugs slow your stomach down, even the food you do eat spends less time in the stretch of gut where a lot of absorption happens.
So the gap opens from two directions at once. Less coming in, and less getting through.
Why less food shows up as a slower brain
Your brain is roughly 2 percent of your body weight and burns around 20 percent of your energy. It is the most expensive organ you own and it never clocks off.
It also cannot store much. It needs a steady delivery of fuel and of the small molecules that turn fuel into usable energy and into neurotransmitters.
Cut the supply line and the brain does not shut down dramatically. It just gets slower and noisier. That is what fog is. It is not a disease. It is a performance drop.
The four gaps that open first
Observational work following GLP-1 users found nutritional deficiencies developing within twelve months. The order was fairly consistent.
Vitamin D. The most common one. It is involved in brain signalling and mood regulation, and low levels are consistently associated with low mood and mental fatigue. Worth being precise here. Correcting a real deficiency helps. Topping up someone who already has enough does not. The largest prevention trial, more than 18,000 adults followed for five years, found no mood benefit from routine supplementation.
B vitamins, especially thiamine (B1) and B12. Thiamine is how your cells convert glucose into energy. Without it your brain literally cannot make ATP efficiently. B12 is needed to maintain myelin, the insulation around your nerve fibres. Low B12 produces exactly the symptom picture people describe: fog, poor memory, tingling in hands and feet, low mood. One correction worth making, because most articles on this topic get it wrong: there is no established evidence that GLP-1 drugs block B12 absorption directly. The risk comes from eating less of it, plus slower gut transit. One more thing to know. If you also take metformin, semaglutide can interfere with the B12 lab assay itself and produce a falsely low reading.
Magnesium. Involved in hundreds of enzyme reactions, plus sleep quality and the stress response. Digestive side effects can drain it faster than usual.
Iron. Carries oxygen. Low iron means a brain running on partial oxygen delivery, and that feels like fog and fatigue well before it shows up as anaemia on a standard blood count. Ask for ferritin, not just haemoglobin.
None of this is exotic. It is the same mechanism we wrote about in the piece on brain inflammation and balance. The brain is a system with inputs. Cut the inputs and output drops.
These symptoms get blamed on the drug. Often they are a correctable deficiency wearing the drug as a costume.
The cortisol part, and why I am being careful with it
Cortisol is my usual subject. I have written about why you wake at 3am and what your cortisol curve is doing. So I want to be honest about where the evidence sits here, because a lot of people online are not being.
Two things are true at once.
First: rapid weight loss is a stressor. Not emotionally. Physically. Losing a lot of weight quickly is a metabolic demand, and your body responds to demand with cortisol. That is not controversial.
Second: the direct GLP-1 to cortisol link is unsettled. Some research, including work presented from Georgia State, shows GLP-1 receptor agonists activating the HPA axis, which is the chain that produces cortisol. Other work points the other way. A randomised crossover trial in healthy volunteers using dulaglutide found no lasting effect on HPA axis activity, though it only had 20 participants and the authors themselves noted that dulaglutide is a large molecule that may not reach the brain the way semaglutide does.
So: plausible, actively researched, not proven. Anyone selling you a supplement on the basis that GLP-1 drugs definitely spike your cortisol is ahead of the data.
What I will say with confidence is this. If you are eating less, sleeping worse, losing weight fast and under normal life pressure on top of that, your stress system is carrying more load than usual. And a stressed brain with a thin nutrient supply is the exact combination that produces fog.
So should I stop taking it?
No. That is not what this article is for, and I am not your doctor.
These medications are doing something genuinely valuable for a lot of people. Weight loss at that scale improves cardiovascular risk, blood sugar, joint load and sleep apnoea. Those are all good for your brain in the long run.
The problem is not the drug. The problem is that the drug creates a nutritional gap and almost nobody is telling people to fill it.
What to actually do
Get tested, do not guess. Ask your doctor for vitamin D, B12, ferritin and a full blood count. If you are on metformin as well, B12 matters even more. Testing beats guessing every time.
Protect your protein. When you are eating less, protein is the first thing that quietly disappears. Muscle loss during rapid weight loss is common and it affects your metabolism, not just your mirror.
Cover the micronutrient floor daily. This is the part most people skip. You are eating half the food, so you are getting half the micronutrients. A comprehensive daily foundation is not optional in that situation.
Protect sleep aggressively. Sleep is when your brain does most of its metabolic housekeeping. If you are already short on fuel, losing sleep on top of it compounds the fog.
Move, even a little. A one year randomised trial published in 2026 found that 150 minutes of moderate aerobic activity per week measurably lowered long term cortisol levels in midlife adults. That is causal evidence, not just correlation, and it is one of the few stress interventions with that quality of proof behind it.
Where Axolt fits
I built Axolt because I hit my own version of this. Not on a GLP-1 drug, but the same underlying problem: a brain doing demanding work on an input supply that was not keeping up.
One sachet covers 47 ingredients across nine brain systems. For someone eating substantially less than they used to, the relevant parts are these. B vitamins including thiamine (B1), B6 and folate (B9) for energy metabolism and homocysteine control. Magnesium bisglycinate for the nervous system and sleep. Vitamin C, potassium, and a polyphenol and antioxidant layer for the protective side.
There is also phosphatidylserine, the one ingredient with a direct line to the stress conversation. I want to be precise about what the evidence shows. The strongest trial gave 400 mg of PS alongside 400 mg of phosphatidic acid for six weeks, and it normalised the cortisol and ACTH response to a laboratory stress test. But it worked only in people who were already chronically stressed, and half that dose did nothing at all. So this is a real effect with real conditions attached, not a blanket cortisol blocker. I have written about its limitations honestly here.
What Axolt is not: it is not a treatment for anything, it does not replace a blood test, and it is not a substitute for prescribed repletion. If your bloods come back low on B12 or iron, that is a conversation with your doctor, not a supplement decision.
If you want the reasoning behind the whole formula, it is laid out on the how it works page.
Peer review
Every claim in this article, with the evidence behind it and what we think its weaknesses are.
| What the article claims | Evidence base | Confidence | Limitation we are flagging |
|---|---|---|---|
| Semaglutide did not slow Alzheimer progression in early stage patients | EVOKE and EVOKE+, two phase 3 randomised placebo controlled trials, 3,808 people, published in The Lancet, March 2026 | High | This tested people who already had a diagnosis. It says nothing about prevention in healthy adults. |
| GLP-1 medications cut daily food intake substantially | Multiple clinical and observational datasets. Reported reductions range from roughly 16 to 40 percent of calories | Moderate to high | The range is wide because it depends on dose, duration and the individual. |
| Lower food intake leads to nutrient gaps within a year | Narrative review of GLP-1 cohorts compared with bariatric surgery protocols. Vitamin D most common, then thiamine and other B vitamins, plus iron, calcium, magnesium and potassium | Moderate | Mostly observational. No large randomised trial has confirmed the rate of deficiency yet. |
| Low B vitamins, magnesium, iron and vitamin D can produce fog, low mood and poor focus | Long established nutritional neuroscience, independent of GLP-1 use | High | Correcting a deficiency restores normal function. It does not make a well fed brain sharper. The largest vitamin D prevention trial, over 18,000 adults across five years, found no mood benefit in people who were not deficient. |
| GLP-1 drugs interact with the cortisol system | Animal work plus limited human data. Some studies show activation of the HPA axis, one randomised crossover trial in healthy volunteers found no lasting effect | Low to moderate | Genuinely unsettled. Anyone telling you this is proven either way is guessing. |
| A specific phosphatidylserine protocol normalises the cortisol response to acute stress | Randomised placebo controlled trial. 75 men, 42 days, 400 mg PS plus 400 mg phosphatidic acid daily | Moderate | The effect appeared only in the chronically high stress subgroup. The 200 mg dose did nothing. Older supporting studies used bovine sourced PS, which is no longer commercially available. |
| GLP-1 drugs do not block vitamin B12 absorption directly | Current clinical guidance finds no established pharmacological link to intrinsic factor or B12 metabolism | Moderate to high | Lower B12 readings are still reported in users. Reduced intake and slower gut transit are the likely explanations, not a direct drug effect. |
| 150 minutes of weekly aerobic exercise lowers long term cortisol | One year randomised trial, 130 midlife adults, cortisol measured in hair, Journal of Sport and Health Science, March 2026 | Moderate to high | Single trial with a modest sample. It is the first causal evidence of its kind, so it has not yet been replicated. |
Frequently asked questions
Does Ozempic cause brain fog?
Brain fog is not a listed effect of the medication itself. What is well documented is that GLP-1 drugs cut food intake by roughly 16 to 40 percent, and that reduced intake leads to nutrient gaps within about a year. Low vitamin D, B vitamins, magnesium and iron all produce fog, fatigue and poor concentration. In most cases the fog is a downstream nutritional effect, not the drug acting on the brain directly.
How long does GLP-1 brain fog last?
If it is driven by a nutrient gap, it tends to build slowly over weeks and months rather than appearing overnight, and it improves when the gap is closed. If it appeared suddenly or comes with tingling, numbness or significant mood change, get bloods done rather than waiting it out.
Which vitamins should I take on a GLP-1 medication?
The most commonly reported deficiencies are vitamin D first, then thiamine and other B vitamins, followed by iron, calcium, magnesium and potassium. Protein also frequently falls short. The right answer depends on your blood results, which is why testing every three to six months is worth doing.
Do GLP-1 drugs raise cortisol?
Unclear. Some animal and human research shows GLP-1 receptor agonists activating the HPA axis, which produces cortisol. A randomised crossover study in healthy volunteers using dulaglutide found no lasting effect. The honest answer is that it is plausible and under investigation. Separately, rapid weight loss is itself a physiological stressor, so cortisol load can rise for reasons that have nothing to do with the drug molecule.
If semaglutide failed for Alzheimer disease, does that mean GLP-1 drugs are bad for the brain?
No. The EVOKE trials tested whether oral semaglutide could slow an existing disease in people already diagnosed. It could not. That is a different question from whether the drug harms a healthy brain, and a different question again from whether the metabolic improvements it produces are good for you over decades.
Can a supplement replace eating properly on a GLP-1?
No. Food is still the primary source, and protein in particular cannot be meaningfully replaced by a micronutrient formula. A daily foundation covers the floor. It does not lift the ceiling. That distinction is one we make throughout our work on long term brain capital.
Key sources
• Efficacy and safety of oral semaglutide 14 mg in early stage symptomatic Alzheimer disease (evoke and evoke+): two phase 3 randomised placebo controlled trials. The Lancet, March 2026.
• Macronutrient and micronutrient supplementation and monitoring for patients on GLP-1 agonists: can we learn from metabolic and bariatric surgery? Narrative review, 2025.
• GLP-1 receptor agonists, good for body weight, bad for micronutrient status? Review of energy intake reduction and micronutrient risk, 2025.
• Effects of glucagon like peptide 1 receptor agonists on the hypothalamic pituitary adrenal axis in healthy volunteers. Journal of Clinical Endocrinology and Metabolism, 2019.
• A soy based phosphatidylserine and phosphatidic acid complex normalises the stress reactivity of the HPA axis in chronically stressed male subjects. Lipids in Health and Disease, 2014.
• Effects of a year long aerobic exercise intervention on neuroendocrine, autonomic and neural correlates of stress, emotion and cardiovascular disease risk in midlife adults. Journal of Sport and Health Science, March 2026.
• Effect of long term vitamin D3 supplementation versus placebo on risk of depression or clinically relevant depressive symptoms (VITAL-DEP). JAMA, 2020.
Related reading
• Why You Wake Up at 3 AM: The Cortisol Spike Explained
• Phosphatidylserine: The Brain Nutrient That Declines With Age
• Brain Capital After 45: How to Protect Your Most Valuable Asset
• The Smarter You Work, the Faster Your Brain Ages
• Axolt Brain Health Pyramid: How We Crafted Our Formula
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results may vary based on individual use. Consult your healthcare provider before starting any new supplement, especially if you have any underlying medical conditions or are taking medications.
Powered by AXOLT. This article is powered by AXOLT, a brand focused on nutrition and long term brain health. AXOLT is not related to the axolotl amphibian, despite similar spelling. All content on this website refers to brain health systems, ingredients, and supplementation.
Powered by AXOLT. IN CONTROL.
